PAVmed Inc.
$9.44
▲
0.31%
2026-04-21 08:45:00
www.pavmed.com
NCM: PAVM
Explore PAVmed Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$60.26 M
Current Price
$9.44
52W High / Low
$28.44 / $6
Stock P/E
150.27
Book Value
$10.01
Dividend Yield
—
ROCE
-89.22%
ROE
-32.34%
Face Value
—
EPS
$-5.63
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
41
Beta
0.81
Debt / Equity
59.86
Current Ratio
0.17
Quick Ratio
0.16
Forward P/E
-0.54
Price / Sales
821.89
Enterprise Value
$82.76 M
EV / EBITDA
-3.81
EV / Revenue
1,165.65
Rating
Strong Buy
Target Price
$40.5
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Net margin remains healthy.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Medtronic plc | $83.14 | 23.25 | $107.11 B | 3.34% | 8.3% | 9.39% | $106.33 / $79.93 | $38.17 |
| 2. | SI-BONE, Inc. | $14.32 | — | $632.45 M | — | -10.47% | -10.97% | $21.89 / $12.15 | $4.07 |
| 3. | ClearPoint Neuro, Inc. | $11.16 | — | $349.74 M | — | -27.78% | -95.64% | $30.1 / $8.27 | $0.95 |
| 4. | Alphatec Holdings, Inc. | $11.55 | — | $1.68 B | — | -10.13% | -6.31% | $23.29 / $9.89 | $0.08 |
| 5. | MaxCyte, Inc. | $0.86 | — | $91.86 M | — | -24.06% | -23.63% | $2.96 / $0.64 | $1.61 |
| 6. | Butterfly Network, Inc. | $5.49 | — | $1.39 B | — | -37.34% | -42.25% | $5.62 / $1.32 | $0.77 |
| 7. | TELA Bio, Inc. | $0.63 | — | $30.55 M | — | -53.21% | -2.23% | $2.2 / $0.5 | $0.14 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0.05 M | 0.01 M | 0.01 M | 0.01 M | 0.01 M | — |
| Operating Profit | -6.65 M | -4.68 M | -4.63 M | -5.43 M | -5.08 M | — |
| Net Profit | -1.26 M | -5.38 M | -11.92 M | 18.97 M | 1.43 M | — |
| EPS in Rs | -0.2 | -0.85 | -1.89 | 3 | 0.23 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0.07 M | 3 M | 2.45 M | 0.38 M |
| Operating Profit | -21.39 M | -44.38 M | -68.8 M | -91.09 M |
| Net Profit | 0.4 M | 39.79 M | -64.17 M | -88.98 M |
| EPS in Rs | 0.06 | 6.3 | -10.16 | -14.09 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 38.81 M | 30.66 M | 33.12 M | 53.98 M |
| Total Liabilities | 16.51 M | 37.69 M | 57.14 M | 43.05 M |
| Equity | 33.97 M | -2.5 M | -53.83 M | -9.68 M |
| Current Assets | 2.56 M | 2.16 M | 24.5 M | 43.93 M |
| Current Liabilities | 14.84 M | 35.45 M | 54.18 M | 41.2 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -5.21 M | -33.55 M | -52.04 M | -70.98 M |
| Investing CF | -0.03 M | -16.18 M | 0.76 M | -4.74 M |
| Financing CF | 5.59 M | 31.28 M | 31.17 M | 38.21 M |
| Free CF | -5.24 M | -33.61 M | -52.28 M | -72.53 M |
| Capex | -0.03 M | -0.06 M | -0.24 M | -1.54 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 22.15% | 550.4% | — | — |
| Earnings Growth % | 162% | 27.88% | — | — |
| Profit Margin % | 1328.58% | -2617.25% | -23602.92% | — |
| Operating Margin % | -1481.74% | -2805.67% | -24161.01% | — |
| Gross Margin % | -61.6% | -161.83% | -858.62% | — |
| EBITDA Margin % | 990.65% | -3088.99% | -26392.57% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-01-02 | 1:0.0333333 |
| 2023-12-07 | 1:0.0666667 |